High Performance in Risk Stratification of Intraductal Papillary Mucinous Neoplasms by Confocal Laser Endomicroscopy Image Analysis with Convolutional Neural Networks (with Video)
Overview
Pharmacology
Radiology
Authors
Affiliations
Background And Aims: EUS-guided needle-based confocal laser endomicroscopy (EUS-nCLE) can differentiate high-grade dysplasia/adenocarcinoma (HGD-Ca) in intraductal papillary mucinous neoplasms (IPMNs) but requires manual interpretation. We sought to derive predictive computer-aided diagnosis (CAD) and artificial intelligence (AI) algorithms to facilitate accurate diagnosis and risk stratification of IPMNs.
Methods: A post hoc analysis of a single-center prospective study evaluating EUS-nCLE (2015-2019; INDEX study) was conducted using 15,027 video frames from 35 consecutive patients with histopathologically proven IPMNs (18 with HGD-Ca). We designed 2 CAD-convolutional neural network (CNN) algorithms: (1) a guided segmentation-based model (SBM), where the CNN-AI system was trained to detect and measure papillary epithelial thickness and darkness (indicative of cellular and nuclear stratification), and (2) a reasonably agnostic holistic-based model (HBM) where the CNN-AI system automatically extracted nCLE features for risk stratification. For the detection of HGD-Ca in IPMNs, the diagnostic performance of the CNN-CAD algorithms was compared with that of the American Gastroenterological Association (AGA) and revised Fukuoka guidelines.
Results: Compared with the guidelines, both n-CLE-guided CNN-CAD algorithms yielded higher sensitivity (HBM, 83.3%; SBM, 83.3%; AGA, 55.6%; Fukuoka, 55.6%) and accuracy (SBM, 82.9%; HBM, 85.7%; AGA, 68.6%; Fukuoka, 74.3%) for diagnosing HGD-Ca, with comparable specificity (SBM, 82.4%; HBM, 88.2%; AGA, 82.4%; Fukuoka, 94.1%). Both CNN-CAD algorithms, the guided (SBM) and agnostic (HBM) models, were comparable in risk stratifying IPMNs.
Conclusion: EUS-nCLE-based CNN-CAD algorithms can accurately risk stratify IPMNs. Future multicenter validation studies and AI model improvements could enhance the accuracy and fully automatize the process for real-time interpretation.
Impact of Artificial Intelligence on Pancreaticobiliary Endoscopy.
Jain A, Pabba M, Jain A, Singh S, Ali H, Vinayek R Cancers (Basel). 2025; 17(3).
PMID: 39941748 PMC: 11815774. DOI: 10.3390/cancers17030379.
Artificial Intelligence in Pancreatic Imaging: A Systematic Review.
Podina N, Gheorghe E, Constantin A, Cazacu I, Croitoru V, Gheorghe C United European Gastroenterol J. 2025; 13(1):55-77.
PMID: 39865461 PMC: 11866320. DOI: 10.1002/ueg2.12723.
Advances for Managing Pancreatic Cystic Lesions: Integrating Imaging and AI Innovations.
Seyithanoglu D, Durak G, Keles E, Medetalibeyoglu A, Hong Z, Zhang Z Cancers (Basel). 2025; 16(24.
PMID: 39766167 PMC: 11674829. DOI: 10.3390/cancers16244268.
Risk Stratification of Pancreatic Cysts With Confocal Laser Endomicroscopy.
Singh R, Perisetti A, Pallav K, Chandan S, De Leon M, Sharma N Gastro Hep Adv. 2024; 1(2):160-170.
PMID: 39131123 PMC: 11307855. DOI: 10.1016/j.gastha.2021.11.003.
Wu C, Lim S, Tan D Clin Endosc. 2024; 57(4):434-445.
PMID: 38978396 PMC: 11294861. DOI: 10.5946/ce.2023.157.